ACTIVE_NOT_RECRUITING

PRISM for Depression and Anxiety in Young Adults With Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer or desmoid tumor may experience. The name of the intervention used in this research study is: -Promoting Resilience in Stress Management (PRISM) Program

Official Title

Treatment Development Study of the Promoting Resilience in Stress Management (PRISM) Intervention for Depression and Anxiety in Young Adults With Cancer

Quick Facts

Study Start:2024-09-06
Study Completion:2026-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06502483

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 39 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. 1. Adults unable to consent, individuals who are not yet adults (age \<18), pregnant women, and prisoners.
  2. 2. Individuals who score less than 10 on both PHQ-9 and GAD-7.
  3. 3. Individuals who are diagnosed with cancer less than 6 weeks at the time of screening (we will be able to approach them again after 6 weeks since diagnosis has passed), or those who completed treatment more than 6 months ago will also be ineligible for this study; they will be offered resources for support, if desired.

Contacts and Locations

Principal Investigator

Samantha Bento, PhD
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Greta J Khanna, PhD, MA
STUDY_DIRECTOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Dana-Farber Cancer Institute
Brighton, Massachusetts, 02135
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Samantha Bento, PhD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute
  • Greta J Khanna, PhD, MA, STUDY_DIRECTOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-06
Study Completion Date2026-02-01

Study Record Updates

Study Start Date2024-09-06
Study Completion Date2026-02-01

Terms related to this study

Keywords Provided by Researchers

  • Cancer Diagnosis
  • Non-Metastatic Neoplasm
  • Anxiety
  • Anxiety Disorders
  • Depression
  • Depression Disorder
  • Depression, Anxiety
  • Young adults with cancer
  • Desmoid tumor

Additional Relevant MeSH Terms

  • Cancer Diagnosis
  • Non-Metastatic Neoplasm
  • Anxiety
  • Anxiety Disorders
  • Depression
  • Depressive Disorder
  • Depression, Anxiety
  • Desmoid